Preoperative (Neoadjuvant) Chemotherapy for Osteogenic Sarcoma: A Ten Year Experience-Reference-Cited by-同舟云学术

Preoperative (Neoadjuvant) Chemotherapy for Osteogenic Sarcoma: A Ten Year Experience

Published:1985-05 Issue:5 Volume:8 Page:659-664
ISSN:0147-7447
Container-title:Orthopedics
language:en
Short-container-title:Orthopedics

Author:

Rosen Gerald

Publisher

SLACK, Inc.

Subject

Orthopedics and Sports Medicine,Surgery

Reference15 articles.

1. 1. Edmonson JH Green SJ IvinsJC.etal: A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma. Journal of Clinical Oncology 1984; 2(3):152-I56.

2. 2. Carter SK: Adjuvant chemotherapy in osteogenic sarcoma: The triump that isn't? Journal of Clinical Oncology 1984; 2(3):147-148.

3. 3. Marcove RC Mik`e V Hajek JV et al: Osteogenic sarcoma under the age of 21. A review of 145 operative cases. J Bone Joint Surg 1970: 52(A):411-423.

4. 4. Sutow WW Sullivan MP Wilbur JR. et al: A study o adjuvant chemotherapy in osteogenic sarcoma. J Clin Pharmacol J975; 7:530-533.

5. 5. Cortes EP Necheles TF Holland JF et al: Adriamycin (ADR ) alone vs. ADR and high-dose methotrexate-citrovorum factor rescue (HDM-CFR) as adjuvant to operable primary osteosarcoma. A randomized study by Cancer and Leukemia Group B (CALGB). Proceedings of the American Association of Cancer Research 1979; 20:412.

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synchronous multifocal osteosarcoma: Report of 4 cases and literature review;Surgery Case Reports;2024-11

2. Orthopedic approaches for bone sarcoma: A bibliometric review of the 50 most cited papers;Journal of Orthopaedics;2023-04

3. Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma;JCO Precision Oncology;2023-03

4. A case of combination treatment of femoral osteosarcoma;MD-Onco;2022-12-14

5. The hypoxia-related signature predicts prognosis, pyroptosis and drug sensitivity of osteosarcoma;Frontiers in Cell and Developmental Biology;2022-09-20